Table 5: Adjusted EBITDA and Free Cash Flow (unaudited)
| ($ in millions) | Three months ended | ||||||||||
| October 1, 2023 | July 2, 2023 | October 2, 2022 | |||||||||
| GAAP Net income (loss) | $ | 792 | $ | 704 | $ | 750 | |||||
| Reconciling items to EBITDA (Non-GAAP) | |||||||||||
| Financial (income) expense | 75 | 74 | 98 | ||||||||
| (Benefit) provision for income taxes | 123 | 158 | 149 | ||||||||
| Depreciation | 163 | 162 | 156 | ||||||||
| Amortization | 110 | 119 | 165 | ||||||||
| EBITDA (Non-GAAP) | $ | 1,263 | $ | 1,217 | $ | 1,318 | |||||
| Reconciling items to adjusted EBITDA (Non-GAAP) | |||||||||||
| Results of equity-accounted investees | 2 | 1 | 4 | ||||||||
| Restructuring | (4 | ) | — | — | |||||||
| Share-based compensation | 103 | 102 | 89 | ||||||||
| Other incidental items | 27 | 21 | 33 | ||||||||
| Adjusted EBITDA (Non-GAAP) | $ | 1,391 | $ | 1,341 | $ | 1,444 | |||||
| Trailing twelve month adjusted EBITDA (Non-GAAP) | $ | 5,384 | $ | 5,437 | $ | 5,299 | |||||
| ($ in millions) | Three months ended | ||||||||||
| October 1, 2023 | July 2, 2023 | October 2, 2022 | |||||||||
| Net cash provided by (used for) operating activities | $ | 988 | $ | 756 | $ | 1,144 | |||||
| Net capital expenditures on property, plant and equipment | (200 | ) | (200 | ) | (281 | ) | |||||
| Non-GAAP free cash flow | $ | 788 | $ | 556 | $ | 863 | |||||
| Trailing twelve month non-GAAP free cash flow | $ | 2,568 | $ | 2,643 | $ | 2,510 | |||||
| Trailing twelve month non-GAAP free cash flow as percent of Revenue | 20 | % | 20 | % | 19 | % | |||||
